SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin is the first successful internet money based on peer-to-peer technology; whereby no central bank or authority is involved in the transaction and production of the Bitcoin currency. It was created by an anonymous individual/group under the name, Satoshi Nakamoto. The source code is available publicly as an open source project, anybody can look at it and be part of the developmental process.  Bitcoin is changing the way we see money as we speak. The idea was to produce a means of exchange, independent of any central authority, that could be transferred electronically in a secure, verifiable and immutable way. It is a decentralized peer-to-peer internet currency making mobile payment easy, very low transaction fees, protects your identity, and it works anywhere all the time with no central authority and banks.  Bitcoin is designed to have only 21 million BTC ever created, thus making it a deflationary currency. Bitcoin uses the SHA-256 hashing algorithm with an average transaction confirmation time of 10 minutes. Miners today are mining Bitcoin using ASIC chip dedicated to only mining Bitcoin, and the hash rate has shot up to peta hashes.  Being the first successful online cryptography currency, Bitcoin has inspired other alternative currencies such as Litecoin, Peercoin, Primecoin, and so on.  The cryptocurrency then took off with the innovation of the turing-complete smart contract by Ethereum which led to the development of other amazing projects such as EOS, Tron, and even crypto-collectibles such as CryptoKitties.

Bitcoin

Bitcoin is trending as the crypto community debates potential short squeezes and market exhaustion, with some anticipating a significant "Uptober" rally. Bullish sentiment is fueled by discussions of institutional adoption and potential supply shocks, while bearish voices point to technical indicators and whale sell-offs. Traders are actively analyzing key moving averages and Fibonacci levels to gauge the next directional move.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: Cybersecurity, Internet of Things (IoT), and Licensing and Other. The Cybersecurity segment includes the brand Cylance, BlackBerry Spark, AtHoc, and SecuSUITE. The IoT segment focuses on software licenses, support, maintenance, and professional services. The Licensing and Other segment involves the intellectual property licensing arrangements and settlement awards. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry ($BB.TSX) is trending amid renewed investor optimism, fueled by strong partnerships and expectations for upcoming earnings. The community is closely watching for continued growth in QNX, a key software platform, and potential revenue from existing royalty backlog.  Many believe a significant breakout is imminent, driven by the company's shift towards cybersecurity and IoT.

JFB Construction Holdings is a commercial and residential real estate construction and development company, which engages in delivering services to commercial and residential markets. It operates through the following segments: Commercial Construction, Residential Construction, and Real Estate Development. The Commercial Construction segment includes all activities related to the construction of commercial properties. The Residential Construction segment focuses on the construction of residential properties including single-family homes and multi-family units. The Real Estate Development segment refers to the acquisition, development, and sale of real estate properties. The company was founded by Joseph F. Basille III on April 9, 2024 and is headquartered in Lantana, FL.

JFB Construction Holdings - Ordinary Shares - Class A

JFB is trending due to a recently announced private placement deal to raise capital. However, some community members are concerned about the dilutive nature of the deal with warrants potentially leading to a price decrease, while others believe the financing will allow the company to pursue growth opportunities.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics is trending after reporting positive Phase 2 trial results for their Nanobody treatment, exceeding expectations and prompting analysts to raise price targets. Community members are actively discussing the potential for the drug to become "best-in-class" and speculating on a possible acquisition, while also acknowledging the risk of a potential public offering and a history of fluctuating stock performance.

Volatility Shares Trust - 2x Solana ETF

Volatility Shares 2x Solana ETF

SOLT is trending as traders discuss its potential for high returns linked to Solana's price movements, with some noting recent bullish options activity. Community members are actively trading the dips and highlighting the ETF's volatility and potential as a cash cow. There's also interest in upcoming dividend payouts and anticipation of Solana reaching new all-time highs.

Blockchain-on-Blockchain (BOB) is a new blockchain built on top of another blockchain called ICP. It's like a special layer on an existing system. BOB creates a secure digital record book that uses ICP's network for safety. BOB uses a system called 'proof-of-on-chain-work': You deploy your own smart contract (canister) at bob.fun. This program solves math problems (hashes). Main computers (mother nodes) give out these problems. Miners solve the problems and tell the mother node. If correct, the mother node adds a new block to the blockchain. The winning miner gets BOB tokens as a reward.

BOB.X is trending as the community discusses its limited supply and upcoming halving event, drawing comparisons to Bitcoin and its potential within the web3 space. Many are highlighting its presence on multiple chains and its relationship to the ICP network. Some users are excited about its potential for significant gains.

One Stop Systems, Inc. engages in the design, manufacture, and marketing of computing modules and systems targeting edge deployments. It deals with the design and manufacture of high-performance customized computer and flash arrays, in-flight entertainment, and connectivity and value-added reseller with minimal customization. It operates through the OSS and OSS Europe segments. The company was founded by Stephen D. Cooper and Mark Gunn in 1998 and is headquartered in Escondido, CA.

One Stop Systems Inc

OSS is trending as investors discuss its potential in AI edge computing, fueled by recent contract wins and partnerships, including a new agreement with Maris Tech. Community talking points include the company's small float, potential for significant growth, and comparisons to other AI and defense sector stocks. Bullish sentiment seems to be driven by expectations around future military contracts and the company's strategic positioning in the growing AI edge computing market.

"What's Updog?" is a Community Led token.

UpDog

UpDog is trending, and the community is actively engaging with the classic "What's UpDog?" joke, creating a playful and lighthearted atmosphere. Built on Solana, UpDog is fostering a community-driven approach, inviting members to participate in the project's development and growth within the memecoin space.

Larimar Therapeutics, Inc. Is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics mitochondrial disorders and Friedreich's ataxia. The company was founded in 2005 and is headquartered in Bala Cynwyd, PA.

Larimar Therapeutics Inc

LRMR is trending as investors anticipate upcoming data releases and reflect on insider trading activity. Community members are discussing potential positive clinical outcomes and speculating on whether the data will be released this month. Some traders are weighing potential risks and rewards, with some seeing a possible breakout.

Zoom Communications, Inc. engages in the provision of a communications and collaboration platform. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East, and Africa. The company was founded by Eric S. Yuan in 2011 and is headquartered in San Jose, CA.

Zoom Communications Inc. - Ordinary Shares - Class A

Zoom Video Communications, Inc.

Zoom is trending amid discussions around its AI-driven growth strategy and a large cash balance, prompting debates on whether it's an undervalued opportunity or a 'value trap'. Community members are actively weighing analyst ratings and upcoming events like Zoomtopia for potential catalysts, while some express concern over competition from larger tech companies. Options activity and technical indicators are also being closely monitored for signs of a significant move.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Deutsche Bank AG Buys 7,282 Shares of Karuna Therapeutics, Inc. (NASDAQ:KRTX)

Deutsche Bank AG raised its holdings in shares of Karuna Therapeutics, Inc. (NASDAQ:KRTX  Free Report) by 16.4% during the third quarter, according to its most recent disclosure with the...

Bristol Myers completes acquisition of Karuna Therapeutics

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Q1 2024 EPS Estimates for Karuna Therapeutics, Inc. (NASDAQ:KRTX) Reduced by Zacks Research

Karuna Therapeutics, Inc. (NASDAQ:KRTX  Free Report)  Zacks Research decreased their Q1 2024 earnings estimates for shares of Karuna Therapeutics in a research report issued to...

Karuna Therapeutics, Inc. (NASDAQ:KRTX) Given Consensus Rating of "Hold" by Analysts

Karuna Therapeutics, Inc. (NASDAQ:KRTX  Get Free Report) has been given an average recommendation of Hold by the sixteen research firms that are currently covering the stock...

Karuna Therapeutics, Inc. (NASDAQ:KRTX) Receives Average Recommendation of "Hold" from Brokerages

Shares of Karuna Therapeutics, Inc. (NASDAQ:KRTX  Get Free Report) have received a consensus recommendation of Hold from the sixteen brokerages that are currently covering the...

Karuna Therapeutics, Inc. Expected to Earn FY2026 Earnings of ($4.32) Per Share (NASDAQ:KRTX)

Karuna Therapeutics, Inc. (NASDAQ:KRTX  Free Report)  Stock analysts at Zacks Research issued their FY2026 earnings estimates for shares of Karuna Therapeutics in a research report...

When Will Karuna Therapeutics, Inc. (NASDAQ:KRTX) Turn A Profit?

With the business potentially at an important milestone, we thought we'd take a closer look at Karuna Therapeutics...

Karuna Therapeutics (KRTX, $329.71) Moving Average Convergence Divergence (MACD) Histogram turned positive on March 14, 2024

This is a Bullish indicator signaling KRTX's price could rise from here. Traders may explore going long the stock or buying call options...

Karuna Therapeutics (KRTX, $329.71) RSI Indicator left the overbought zone on March 14, 2024

This is a signal that KRTX's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...

Karuna Therapeutics gains as HSR waiting period for Bristol-Myers deal expires

Karuna Therapeutics gains as HSR waiting period for Bristol-Myers deal expires...

Karuna Therapeutics is a biopharmaceutical company that develops treatments for psychiatric and neurological conditions. Karuna Therapeutics creates drugs that can significantly improve the lives of people who suffer from neurological and psychiatric illnesses, with a particular focus on schizophrenia and the behavioral symptoms of Alzheimer's disease. The company is skilled in neuroscience and has creative ideas for finding and developing new drugs. Karuna Therapeutics isÂ advancing a pipeline of innovative drugs since its inception with the aim of significantly improving the lives of people suffering from these difficult conditions.

Karuna Therapeutics Inc

Will the U.S. government shut down in 2025? 
 
*Powered by Polymarket

KRTX
Karuna Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest KRTX News

KRTX Karuna Therapeutics Inc